Human
Transforming existing hypodermically injected vaccines into a plant-based oral solid dose format — addressing SARS-CoV-2, Hepatitis B, HPV, RSV, Meningitis, Malaria, and more.
View human applications →
Applications
Market opportunities
The market opportunities for the PlantPharm BioMed technology include animal as well as human applications. Learn more about each sector opportunity below.
Animal Health
Pelletized feed vaccines for farmed animals, wildlife (via bait stations), and companion animals — no hypodermic needle required.
View animal health →
Aquaculture
An economical oral vaccine option for farm-raised fish and shrimp, eliminating individual injection or immersion methods.
View aquaculture →
Investing
Learn about investing in PlantPharm
PlantPharm BioMed will be seeking investors passionate about biotechnology and a more sustainable global healthcare system.
PlantPharm plans to offer its Capital Stock at some time in the near future — stay tuned.